Dijkzigt Hospital Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2001
NCT00129857
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2001

Timeline

NOW
  • Now

Alternative names

Dept. of Neurosurgery, Dijkzigt Hospital, Rotterdam, Holland

Active Ingredients

Drugs in Phase 3 Trials (1)

cannabidiol (Epidiolex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Injuries (Phase 3)

Brain Injuries, Traumatic (Phase 3)

Wounds and Injuries (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1